• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

45 and Up 研究队列中子宫内膜癌和卵巢癌的诊断途径。

Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.

机构信息

The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, 153 Dowling St, Woolloomooloo, Sydney, NSW, 2011, Australia.

Cancer Council NSW, Sydney, NSW, Australia.

出版信息

Cancer Causes Control. 2023 Jan;34(1):47-58. doi: 10.1007/s10552-022-01634-2. Epub 2022 Oct 9.

DOI:10.1007/s10552-022-01634-2
PMID:36209449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9816254/
Abstract

PURPOSE

To determine pathways to endometrial or ovarian cancer diagnosis by comparing health service utilization between cancer cases and matched cancer-free controls, using linked health records.

METHODS

From cancer registry records, we identified 238 incident endometrial and 167 ovarian cancer cases diagnosed during 2006-2013 in the Australian 45 and Up Study cohort (142,973 female participants). Each case was matched to four cancer-free controls on birthdate, sex, place of residence, smoking status, and body mass index. The use of relevant health services during the 13-18-, 7-12-, 0-6-, and 0-1-months pre-diagnosis for cases and the corresponding dates for their matched controls was determined through linkage with subsidized medical services and hospital records.

RESULTS

Healthcare utilization diverged between women with cancer and controls in the 0-6-months, particularly 0-1 months, pre-diagnosis. In the 0-1 months, 74.8% of endometrial and 50.3% of ovarian cases visited a gynecologist/gynecological oncologist, 11.3% and 59.3% had a CA125 test, 5.5% and 48.5% an abdominal pelvic CT scan, and 34.5% and 30.5% a transvaginal pelvic ultrasound, respectively (versus ≤ 1% of matched controls). Moreover, 25.1% of ovarian cancer cases visited an emergency department in the 0-1-months pre-diagnosis (versus 1.3% of matched controls), and GP visits were significantly more common for cases than controls in this period.

CONCLUSION

Most women with endometrial or ovarian cancer accessed recommended specialists and tests in the 0-1-months pre-diagnosis, but a high proportion of women with ovarian cancer visited an emergency department. This reinforces the importance of timely specialist referral.

摘要

目的

通过比较癌症病例和匹配的无癌症对照者的卫生服务利用情况,利用关联健康记录确定子宫内膜癌或卵巢癌诊断的途径。

方法

从癌症登记记录中,我们在澳大利亚 45 岁及以上研究队列(142973 名女性参与者)中确定了 2006-2013 年间诊断的 238 例子宫内膜癌和 167 例卵巢癌病例。每个病例都按出生日期、性别、居住地、吸烟状况和体重指数与 4 名无癌症对照者相匹配。通过与补贴医疗服务和医院记录的链接,确定了病例和相应对照者在诊断前 13-18 个月、7-12 个月、0-6 个月和 0-1 个月期间的相关卫生服务使用情况。

结果

在诊断前 0-6 个月,尤其是 0-1 个月期间,癌症女性和对照组之间的医疗保健使用情况出现差异。在 0-1 个月期间,74.8%的子宫内膜癌病例和 50.3%的卵巢癌病例看了妇科医生/妇科肿瘤医生,11.3%和 59.3%做了 CA125 测试,5.5%和 48.5%做了腹部盆腔 CT 扫描,34.5%和 30.5%做了阴道超声检查(而匹配对照组的比例均≤1%)。此外,25.1%的卵巢癌病例在诊断前 0-1 个月期间看了急诊(而匹配对照组的比例为 1.3%),而且在这段时间内,看全科医生的病例明显多于对照组。

结论

大多数子宫内膜癌或卵巢癌患者在诊断前 0-1 个月内接受了推荐的专家和检查,但相当一部分卵巢癌患者去了急诊。这再次强调了及时转介专家的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be58/9816254/73147b1e1016/10552_2022_1634_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be58/9816254/48f8662ebed4/10552_2022_1634_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be58/9816254/73147b1e1016/10552_2022_1634_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be58/9816254/48f8662ebed4/10552_2022_1634_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be58/9816254/73147b1e1016/10552_2022_1634_Fig2_HTML.jpg

相似文献

1
Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.45 and Up 研究队列中子宫内膜癌和卵巢癌的诊断途径。
Cancer Causes Control. 2023 Jan;34(1):47-58. doi: 10.1007/s10552-022-01634-2. Epub 2022 Oct 9.
2
The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.澳大利亚可预防的子宫内膜癌和卵巢癌负担:一项汇总队列研究。
Gynecol Oncol. 2019 Jun;153(3):580-588. doi: 10.1016/j.ygyno.2019.03.102. Epub 2019 Mar 29.
3
The gynecological surveillance of women with Lynch syndrome in Sweden.瑞典林奇综合征女性的妇科监测
Gynecol Oncol. 2015 Sep;138(3):717-22. doi: 10.1016/j.ygyno.2015.07.016. Epub 2015 Jul 12.
4
Nut and peanut butter intake are not directly associated with the risk of endometrial or ovarian cancer: Results from a Dutch prospective cohort study.坚果和花生酱的摄入与子宫内膜癌或卵巢癌的风险无直接关联:一项荷兰前瞻性队列研究的结果。
Clin Nutr. 2020 Jul;39(7):2202-2210. doi: 10.1016/j.clnu.2019.09.008. Epub 2019 Sep 26.
5
Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.澳大利亚卵巢癌的医疗服务费用:45 岁及以上人群研究的估计。
PLoS One. 2023 Apr 18;18(4):e0282851. doi: 10.1371/journal.pone.0282851. eCollection 2023.
6
The effect of statins on risk and survival of gynecological malignancies.他汀类药物对妇科恶性肿瘤风险和生存的影响。
Gynecol Oncol. 2013 Sep;130(3):615-9. doi: 10.1016/j.ygyno.2013.05.025. Epub 2013 May 26.
7
[Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].23例同时性双原发性妇科恶性肿瘤的临床分析
Zhonghua Fu Chan Ke Za Zhi. 2022 May 25;57(5):352-360. doi: 10.3760/cma.j.cn112141-20220214-00086.
8
Socio-demographic factors, comorbidity and diagnostic delay among women diagnosed with cervical, endometrial or ovarian cancer.社会人口因素、合并症与被诊断患有宫颈癌、子宫内膜癌或卵巢癌的女性的诊断延迟。
Eur J Cancer Care (Engl). 2011 Sep;20(5):653-61. doi: 10.1111/j.1365-2354.2011.01259.x. Epub 2011 Jul 19.
9
The effect of bisphosphonates on the risk of endometrial and ovarian malignancies.双磷酸盐对子宫内膜和卵巢恶性肿瘤风险的影响。
Gynecol Oncol. 2014 May;133(2):309-13. doi: 10.1016/j.ygyno.2014.02.014. Epub 2014 Feb 18.
10
Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective.对高危和一般风险女性进行CA125和经阴道超声的卵巢癌年度监测是无效的。
BJOG. 2007 Dec;114(12):1500-9. doi: 10.1111/j.1471-0528.2007.01499.x. Epub 2007 Sep 27.

本文引用的文献

1
Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).九个国际司法管辖区的卵巢癌诊断途径和时间间隔;国际癌症基准伙伴关系(ICBP)的研究结果。
Br J Cancer. 2022 Sep;127(5):844-854. doi: 10.1038/s41416-022-01844-0. Epub 2022 May 26.
2
Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause.准确分类绝经状态用于研究:考虑年龄、自我报告绝经和可能掩盖绝经发生的因素的逐步指导和详细算法。
BMC Res Notes. 2022 Mar 4;15(1):88. doi: 10.1186/s13104-022-05970-z.
3
Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
基于美国经典症状表现的卵巢癌诊断时间的影响因素。
Cancer. 2021 Nov 15;127(22):4151-4160. doi: 10.1002/cncr.33829. Epub 2021 Aug 4.
4
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.英国卵巢癌筛查协作试验(UKCTOCS)长期随访后的卵巢癌人群筛查和死亡率:一项随机对照试验。
Lancet. 2021 Jun 5;397(10290):2182-2193. doi: 10.1016/S0140-6736(21)00731-5. Epub 2021 May 12.
5
Patterns of surgical care for women with ovarian cancer in New South Wales.新南威尔士州女性卵巢癌手术护理模式。
Aust N Z J Obstet Gynaecol. 2020 Aug;60(4):592-597. doi: 10.1111/ajo.13180. Epub 2020 May 26.
6
Psychological distress among carers and the moderating effects of social support.照顾者的心理困扰及社会支持的调节作用。
BMC Psychiatry. 2020 Apr 6;20(1):154. doi: 10.1186/s12888-020-02571-7.
7
Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study.诊断时癌症的表现症状和分期:一项基于人群的横断面研究证据。
Lancet Oncol. 2020 Jan;21(1):73-79. doi: 10.1016/S1470-2045(19)30595-9. Epub 2019 Nov 6.
8
Patient and primary care delays in the diagnostic pathway of gynaecological cancers: a systematic review of influencing factors.妇科癌症诊断路径中患者和初级保健的延误:影响因素的系统评价。
Br J Gen Pract. 2019 Feb;69(679):e106-e111. doi: 10.3399/bjgp19X700781. Epub 2019 Jan 14.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.卵巢癌筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2018 Feb 13;319(6):595-606. doi: 10.1001/jama.2017.21421.